ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Media Advisory: Surescripts to Present at AHIP 2024 On the Value of Clinical Data and Achieving True Interoperability for Health Plans

Surescripts®, the nation’s leading health information network, will host a panel discussion, True Clinical Data & Interoperability – Shaping Member Experience and Outcomes, on June 12 at 11:15 a.m., at AHIP 2024 in Las Vegas.

As part of the panel discussion, Surescripts will share more about its work to advance health intelligence sharing through its subsidiary, Surescripts Health Information Network, LLCTM, that recently advanced to the candidate phase in the process of becoming a Qualified Health Information NetworkTM.

“Decades of collaboration with industry leaders and Surescripts Network Alliance participants has enabled health intelligence sharing at scale, with nearly 24 billion exchanges of patient-specific clinical and benefit information in 2023, leading to better informed patient care nationwide,” said Matt Hartzler, Director, Product Commercialization for Surescripts. “We look forward to connecting with industry colleagues at AHIP 2024 and for the opportunity to collaborate on innovative technologies that create efficiencies within clinical workflows and reduce administrative costs while advancing interoperability that can address the biggest challenges facing healthcare today.”

Learn more about simplifying the path to nationwide interoperability and check out Surescripts QHIN Readiness Guide to prepare to connect with a QHIN.

Surescripts at AHIP 2024:

Stop by booth #1501 during exhibit hall hours.

Expert panel: True Clinical Data & Interoperability – Shaping Member Experience and Outcomes

When & Where: Wednesday, June 12, at 11:15 a.m., at the Wynn Las Vegas

Overview: The broader availability and use of clinical data has the potential to deliver value to health insurance providers and members alike. Join this session to explore data-driven market dynamics, including clinical data interoperability from external sources and expansion of internal clinical data sources and tools. Learn how both dynamics can impact care insights, cost of care, and outcomes.

Panelists:

  • Matt Hartzler, Director, Product Commercialization, Surescripts
  • Terry Douglas, Director, Product Marketing, Surescripts
  • Andrew Borgschulte, Principal Product Marketing Manager, Surescripts

More Ways to Connect with Surescripts:

AHIP Webinar: Surescripts will host a panel discussion on Increasing Access to Care Through Care Team Evolution on June 10, at 2:00 p.m. ET.

  • Register to learn more and hear from industry leaders including Brigid K. Groves, PharmD, MS, Vice President of Professional Affairs, American Pharmacists Association; Troy Trygstad, PharmD, MBA, PhD, Executive Director, CPSEN USA; and Meg Murphy, PharmD, Pharmacy and Regulatory Affairs Manager, Surescripts.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.